NEW YORK – Which articles gained the most attention from GenomeWeb's readers last week? Here are the top five:
- FDA Approves Illumina Cancer Genomic Profiling Assay as CDx for Kinase Inhibitors From Bayer, Lilly
- BGI Unveils New Nanopore Sequencing Platform
- MGI Tech Reports 16 Percent Revenue Decline, Workforce Reduction in H1 2024
- Tome Biosciences to Lay off 131 Employees
- Qiagen, AstraZeneca Expand CDx Collaboration Beyond Cancer